Clinical Trial Update: Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Gymnema Sylvestre for metabolic syndrome and insulin management has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Gymnema sylvestre (Gymnema sylvestre)

Snippet

Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-06-03